Study of Safety, Tolerability, and Pharmacokinetics of REGN3470-3471-3479 in Healthy Adult Volunteers
Clinical trial NCT02777151 · COMPLETED
Trial details
- NCT number
- NCT02777151
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-27
- Primary completion
- 2017-04-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.